Literature DB >> 23384508

Haemostasis in neurosurgery: what is the evidence for gelatin-thrombin matrix sealant?

Henry H I Yao1, Matthew K H Hong, Katharine J Drummond.   

Abstract

Strict intra-operative haemostasis is essential in the practice of neurosurgery. Over the last century, haemostatic methods have advanced significantly and the modern surgeon is now faced with an array of haemostatic agents, each with subtly different qualities and proven in different contexts with various levels of evidence. The popularity of endoscopic and laparoscopic procedures in other surgical specialties has encouraged the introduction of novel agents to achieve haemostasis where conventional methods have proven difficult. These agents are beginning to find a role in routine use for surgery in both the elective and emergent settings. This article reviews the mechanisms of different haemostasis methods and the current evidence for their use in neurosurgery, with a focus on the more recently introduced gelatin-thrombin matrix sealant (Floseal [Baxter, Hayward, CA, USA]).
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23384508     DOI: 10.1016/j.jocn.2012.09.005

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  9 in total

1.  Haemostatic material (Surgicel®) mimicking residual tumour: magnetic resonance imaging findings in operated pediatric neuro-oncology cases.

Authors:  Serena Staglianò; Felice D'Arco; Ai Peng Tan; Owase Jeelani; Giovanni Morana; Kshitij Mankad
Journal:  Quant Imaging Med Surg       Date:  2018-10

2.  Nano-hemostats and a Pilot Study of Their Use in a Large Animal Model of Major Vessel Hemorrhage in Endoscopic Skull Base Surgery.

Authors:  Alistair Jukes; Jae Murphy; Sarah Vreugde; Alkis Psaltis; P J Wormald
Journal:  J Neurol Surg B Skull Base       Date:  2016-12-12

3.  Imaging features of a gelatin-thrombin matrix hemostatic agent in the intracranial surgical bed: a unique space-occupying pseudomass.

Authors:  K O Learned; S Mohan; I Z Hyder; L J Bagley; S Wang; J Y Lee
Journal:  AJNR Am J Neuroradiol       Date:  2013-11-01       Impact factor: 3.825

4.  Is the use of hemostatic matrix (Floseal) and alkylene oxide copolymer (Ostene) safe in spinal laminectomies? Peridural fibrosis assessment.

Authors:  Oktay Gurcan; Ahmet Gurhan Gurcay; Atilla Kazanci; Evrim Onder; Salim Senturk; Murad Bavbek
Journal:  Acta Orthop Traumatol Turc       Date:  2017-02-27       Impact factor: 1.511

5.  Reactive gliosis mimicking tumor recurrence - a case series documenting MRI abnormalities and neuropathological correlates.

Authors:  Hugh Kearney; Jane Cryan; Alan Beausang; Seamus Looby; Francesca M Brett
Journal:  Clin Neuropathol       Date:  2018 May/Jun       Impact factor: 1.368

6.  Efficacy of a topical gelatin-thrombin hemostatic matrix, FLOSEAL®, in intracranial tumor resection.

Authors:  Dai Kamamoto; Tokunori Kanazawa; Eriko Ishihara; Kaoru Yanagisawa; Hideyuki Tomita; Ryo Ueda; Masahiro Jinzaki; Kazunari Yoshida; Masahiro Toda
Journal:  Surg Neurol Int       Date:  2020-02-07

7.  Efficacy and Safety of Novel Beta-Chitin Patches as Haemostat in Rat Vascular and Neurosurgical Model.

Authors:  Ahad Sabab; Rajan Sundaresan Vediappan; John Finnie; C John McAdam; Alistair Jukes; Sarah Vreugde; Peter-John Wormald
Journal:  Front Surg       Date:  2022-04-08

8.  Effectiveness of Gelatin-Thrombin Matrix Sealants (Floseal®) on Postoperative Spinal Epidural Hematoma during Single-Level Lumbar Decompression Using Biportal Endoscopic Spine Surgery: Clinical and Magnetic Resonance Image Study.

Authors:  Ju-Eun Kim; Hyun-Seung Yoo; Dae-Jung Choi; Eugene J Park; Jin-Ho Hwang; Jeong-Duk Suh; Jun-Hyug Yoo
Journal:  Biomed Res Int       Date:  2020-07-08       Impact factor: 3.411

Review 9.  Use of a gelatin-thrombin hemostatic matrix in obstetrics and gynecological surgery.

Authors:  Selim Mısırlıoğlu; Engin Türkgeldi; Hande Yağmur; Bülent Urman; Barış Ata
Journal:  Turk J Obstet Gynecol       Date:  2018-09-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.